ATE229650T1 - Verfahren zur diagnose von diabetes und praediabetischer bedingungen - Google Patents

Verfahren zur diagnose von diabetes und praediabetischer bedingungen

Info

Publication number
ATE229650T1
ATE229650T1 AT94906796T AT94906796T ATE229650T1 AT E229650 T1 ATE229650 T1 AT E229650T1 AT 94906796 T AT94906796 T AT 94906796T AT 94906796 T AT94906796 T AT 94906796T AT E229650 T1 ATE229650 T1 AT E229650T1
Authority
AT
Austria
Prior art keywords
gad
pct
patient
preediabetic
conditions
Prior art date
Application number
AT94906796T
Other languages
English (en)
Inventor
Ian Reay Mackay
Merrill Joy Rowley
Paul Zev Zimmet
Original Assignee
Univ Monash
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Monash filed Critical Univ Monash
Application granted granted Critical
Publication of ATE229650T1 publication Critical patent/ATE229650T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT94906796T 1993-02-09 1994-02-09 Verfahren zur diagnose von diabetes und praediabetischer bedingungen ATE229650T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPL716893 1993-02-09
PCT/AU1994/000056 WO1994018568A1 (en) 1993-02-09 1994-02-09 Methods for the diagnosis of diabetes and prediabetic conditions

Publications (1)

Publication Number Publication Date
ATE229650T1 true ATE229650T1 (de) 2002-12-15

Family

ID=3776693

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94906796T ATE229650T1 (de) 1993-02-09 1994-02-09 Verfahren zur diagnose von diabetes und praediabetischer bedingungen

Country Status (12)

Country Link
US (1) US5770381A (de)
EP (1) EP0686262B1 (de)
JP (1) JP3510889B2 (de)
AT (1) ATE229650T1 (de)
CA (1) CA2155677A1 (de)
DE (1) DE69431874D1 (de)
IL (1) IL108587A (de)
NZ (1) NZ261541A (de)
SG (1) SG45161A1 (de)
TW (1) TW305936B (de)
WO (1) WO1994018568A1 (de)
ZA (1) ZA94845B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821334A (en) * 1996-01-26 1998-10-13 Vanderbilt University Insulin-dependent diabetes mellitus-specific chimeric polypeptides
FR2759701B1 (fr) * 1997-02-19 1999-06-04 Inst Nat Sante Rech Med Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
WO2000073800A1 (en) * 1999-06-01 2000-12-07 Kyokuto Pharmaceutical Industrial Co., Ltd. Method for assaying anti-gad antibody and kit
US8852873B2 (en) 2012-04-13 2014-10-07 Diabetomics, Llc Maternal biomarkers for gestational diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682906B1 (en) * 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
EP0572478B1 (de) * 1991-02-22 2005-09-07 The Walter And Eliza Hall Institute Of Medical Research Hbgad und higad polypeptide und nukleinsäuren und deren verwendung zur diagnose und behandlung von gad autoantigen assoziierten krankheiten
AU1749692A (en) * 1991-05-03 1992-12-21 Novo Nordisk A/S Islet cell autoantigen (gad) for the detection of preclinical diabetes

Also Published As

Publication number Publication date
JP3510889B2 (ja) 2004-03-29
EP0686262B1 (de) 2002-12-11
JPH08506417A (ja) 1996-07-09
CA2155677A1 (en) 1994-08-18
SG45161A1 (en) 1998-01-16
EP0686262A1 (de) 1995-12-13
TW305936B (de) 1997-05-21
IL108587A0 (en) 1994-05-30
EP0686262A4 (de) 1997-06-04
WO1994018568A1 (en) 1994-08-18
DE69431874D1 (de) 2003-01-23
US5770381A (en) 1998-06-23
IL108587A (en) 1998-01-04
ZA94845B (en) 1994-11-11
NZ261541A (en) 1996-09-25

Similar Documents

Publication Publication Date Title
DeRose et al. Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment
Niemelä et al. Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum
ATE117806T1 (de) Bestimmungsmethode für glykosyliertes hämoglobin.
Ooi et al. Serum immune complexes in membranoproliferative and other glomerulonephritides
LU91015I2 (fr) Recombinate (Rurioctocog alfa) dans toutes ses formes couvertes par le brevet de base
DK557089D0 (da) Proeve for type iii collagennedbrydning
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
CA2104225A1 (en) Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
Dybkaer Unit" katal" for catalytic activity
ATE68600T1 (de) Satz und verfahren zur diagnose der iganephropathie.
Shell et al. Early appearance of MB-creatine kinase activity in nontransmural myocardial infarction detected by a sensitive assay for the isoenzyme
ATE229650T1 (de) Verfahren zur diagnose von diabetes und praediabetischer bedingungen
KR930703612A (ko) 항-알엔에이(rna) 항체의 검출 방법
Hänsch et al. Effect of aspirin on the complement system in vitro
EP1757704A3 (de) Methoden zur Erkennung von Mutationene in Verbindung mit hypertropher Kardiomyopathie
DE69508605D1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
Yokokawa et al. Presence of anti-DNA antibody in diabetes mellitus: its relation to the duration of diabetes and diabetic complications
DE59305225D1 (de) Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
Gochman et al. The amino acid decarboxylase of salivary sediment
SU1274682A1 (ru) Способ диагностики сальмонеллеза у детей
Kjellman et al. Cognitive and affective functions in patients with affective disorders treated with lithium AN ASSESSMENT BY QUESTIONNAIRE
SU544413A1 (ru) Способ хранени м са
RU2721726C2 (ru) Устройство экспресс-диагностирования сердечной деятельности
RU97112319A (ru) Способ определения стадии патологического процесса в тестах оценки функциональной активности лимфоцитов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties